跳至主要内容
临床试验/CTRI/2022/09/045139
CTRI/2022/09/045139尚未招募不适用

Effect of preanaesthetic dexmedetomidine nebulization in hemodynamic responses following laryngoscopy and intubation

Dr Deeksha B G1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年5月9日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
To study the effect of pre operative dexmedetomidine nebulization on mean arterial pressure following laryngoscopy and intubation

研究概览

简要总结

Direct laryngoscopy and intubation are noxious stimuli and are associated with transient but unpredictable and variable haemodynamic changes. This response occurs within 30 seconds after intubation and lasts less than 10 minutes. The consequences of laryngoscopy and intubation may precipitate ischemia, arrhythmias, cerebrovascular stroke, pulmonary oedema, increase in intracranial pressure in vulnerable group. Till date, numerous drugs and various routes have been tried to attenuate this stress response such as opioids, vasodilators, beta blockers, calcium channel blockers, intravenous lignocaine but none of the agents proved to be ideal.

Dexmedetomidine is a highly selective alpha 2 adrenoreceptor agonist. It is a short acting drug having sympatholytic, sedative, hypnotic, anxiolytic, analgesic and anti-sialogogue properties. Its pleiotropic effect have led to its increasing use for reducing anaesthesia and analgesic requirements in the perioperative period.

The efficacy of dexmedetomidine in attenuating the hemodynamic response to laryngoscopy and intubation has been studied through intravenous, intranasal and intramuscular routes. However, it is noted that intravenous administration causes bradycardia, hypotension and even cardiac arrest [2] and intranasal administration may be associated with nasal irritation, cough, vocal cord irritation or laryngospasm.

Inhalation of nebulized drug is an alternative method of administration that is relatively easy to set up, does not require venipuncture, and is associated with high bioavailability of the administered drug.

Nebulised dexmedetomidine has been used as an effective premedication in paediatric patients in the doses of 1 and 2mcg/kg. Few studies are available which have evaluated either 1 or 2 mcg/kg dexmedetomidine in attenuating stress response to intubation. Hence, our study and we hypothesize that dexmedetomidine nebulisation at 1 mcg/kg provides good haemodynamic stability and sedation.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • All patients posted for surgery under general anaesthesia with Endotracheal intubation.

排除标准

  • Patients with Difficult Airway Pregnancy and Lactation.

结局指标

主要结局

To study the effect of pre operative dexmedetomidine nebulization on mean arterial pressure following laryngoscopy and intubation

时间窗: First 5 minutes and 10th minute following laryngoscopy and intubation

次要结局

  • Changes in the heart rate(Following laryngoscopy and intubation)
  • Sedation score(Pre operatively from the start of nebulization till end of nebulization for every 5 minutes)
  • Total doses of propofol used(At the time of induction)

研究者

发起方
Dr Deeksha B G
申办方类型
Other [Self ]

研究点 (1)

Loading locations...

相似试验